Nishi Karunasinghe

85 Park Road
Auckland, AUK 1023, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Applicability of the New Zealand-eating behavior questionnaire to predict weight loss responses to naltrexone/bupropion: a proof-of-concept trial.

Applicability of the New Zealand-eating behavior questionnaire to predict weight loss responses to naltrexone/bupropion: a proof-of-concept trial.

Journal: Obesity pillars

Published: October 30, 2025

Zinc in Prostate Health and Disease: A Mini Review.

Zinc in Prostate Health and Disease: A Mini Review.

Journal: Biomedicines

Published: November 03, 2022

Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions.

Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions.

Journal: Scientific reports

Published: July 14, 2021

Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis.

Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis.

Journal: Scientific reports

Published: May 02, 2020

Selenium Supplementation and Prostate Health in a New Zealand Cohort.

Selenium Supplementation and Prostate Health in a New Zealand Cohort.

Journal: Nutrients

Published: November 07, 2019

Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand.

Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand.

Journal: PloS one

Published: March 27, 2019

Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts.

Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts.

Journal: PloS one

Published: February 18, 2018

Aggressive prostate cancer incidence in New Zealand-"united we fall, divided we stand".

Aggressive prostate cancer incidence in New Zealand-"united we fall, divided we stand".

Journal: The New Zealand medical journal

Published: December 04, 2017

Effect of ageing and single nucleotide polymorphisms associated with the risk of aggressive prostate cancer in a New Zealand population.

Effect of ageing and single nucleotide polymorphisms associated with the risk of aggressive prostate cancer in a New Zealand population.

Journal: Molecular bioSystems

Published: August 08, 2017

Cancer-preventive Properties of an Anthocyanin-enriched Sweet Potato in the APCMIN Mouse Model.

Cancer-preventive Properties of an Anthocyanin-enriched Sweet Potato in the APCMIN Mouse Model.

Journal: Journal of cancer prevention

Published: July 26, 2017

Effect of Androgen Deprivation Therapy on Bone Mineral Density in a Prostate Cancer Cohort in New Zealand: A Pilot Study.

Effect of Androgen Deprivation Therapy on Bone Mineral Density in a Prostate Cancer Cohort in New Zealand: A Pilot Study.

Journal: Clinical Medicine Insights. Oncology

Published: June 11, 2017

SNP-SNP interactions as risk factors for aggressive prostate cancer.

SNP-SNP interactions as risk factors for aggressive prostate cancer.

Journal: F1000Research

Published: April 19, 2017

Showing 1-12 of 29

Last Updated: 09/26/2026